We are live on
!
Find out more
RP
Rowlandmiller & Partners Portfolio holdings
AUM
$549M
1-Year Est. Return
36.2%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$518M
AUM Growth
+$9.1M
(+1.8%)
Cap. Flow
-$2.24M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
39.46%
Holding
198
New
11
Increased
59
Reduced
73
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$504K |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$291K |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$290K |
| 4 |
Altria Group
MO
|
+$255K |
| 5 |
Amazon
AMZN
|
+$210K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$930K |
| 2 |
Weyerhaeuser
WY
|
+$370K |
| 3 |
Walmart Inc
WMT
|
+$360K |
| 4 |
Apple
AAPL
|
+$359K |
| 5 |
Skyworks Solutions
SWKS
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.81% |
| 2 | Financials | 15.18% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 11.3% |
| 5 | Consumer Staples | 9.88% |
Similar funds
AMG
AI
LWP
WCP
ALA
BCM
HIS
AA
Rowlandmiller & Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Rowlandmiller & Partners held 198 positions worth $518M, up 1.8% from $509M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Rowlandmiller & Partners's Q4 2025 filing shows 11 new, 59 increased, 73 reduced and 2 closed positions. Its largest new stake was Schwab US Dividend Equity ETF: 10,663 shares worth $293K. The largest sale was Eli Lilly, an estimated $930K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Rowlandmiller & Partners's largest Q4 2025 buy was Schwab US Dividend Equity ETF: 10,663 shares worth $293K.
- Rowlandmiller & Partners added most to Vanguard Morningstar Total Stock Market ETF in Q4 2025, an estimated $504K increase.
- Rowlandmiller & Partners's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $930K.
- Rowlandmiller & Partners fully exited F5 in Q4 2025, selling an estimated $284K.
- Rowlandmiller & Partners's ten largest holdings make up 39% of its $518M portfolio in Q4 2025.
- Rowlandmiller & Partners opened 11 new positions and closed 2 in Q4 2025.
- Rowlandmiller & Partners's portfolio value rose 1.8% quarter-over-quarter to $518M.
Based on Rowlandmiller & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.